61 results on '"Migliorini, Angela"'
Search Results
2. Long-Term Durability of Transcatheter Aortic Valve Implantation With Self-Expandable Valve System (from a Real-World Registry)
3. Long-Term Mortality Comparison of Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock and Treated With Culprit-Only or Multivessel Percutaneous Coronary Intervention
4. On-Treatment Platelet Reactivity is a Predictor of Adverse Events in Peripheral Artery Disease Patients Undergoing Percutaneous Angioplasty
5. Relationship between CHA2DS2-VASc score, coronary artery disease severity, residual platelet reactivity and long-term clinical outcomes in patients with acute coronary syndrome
6. APpropriateness Assessment in Antiplatelet THerapY (APATHY) registry: Insight from current clinical practice
7. Early changes of left ventricular filling pattern after reperfused ST-elevation myocardial infarction and doxycycline therapy: Insights from the TIPTOP trial
8. Long-Term Primary Patency Rate After Nitinol Self-Expandable Stents Implantation in Long, Totally Occluded Femoropopliteal (TASC II C & D) Lesions
9. A New Risk Score to Predict Long-Term Cardiac Mortality in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock and Treated With Primary Percutaneous Intervention
10. Morphine use and myocardial reperfusion in patients with acute myocardial infarction treated with primary PCI
11. Angiographic and Clinical Outcomes After Everolimus-Eluting Stenting for Unprotected Left Main Disease and High Anatomic Coronary Complexity
12. High on-aspirin platelet reactivity predicts cardiac death in acute coronary syndrome patients undergoing PCI
13. Prognostic impact of high residual platelet reactivity after chronic total occlusion percutaneous coronary intervention in patients with diabetes mellitus
14. Prasugrel in Clopidogrel Nonresponders Undergoing Percutaneous Coronary Intervention: The RECLOSE-3 Study (REsponsiveness to CLOpidogrel and StEnt Thrombosis)
15. Impact on Left Ventricular Function and Remodeling and on 1-Year Outcome in Patients With Left Bundle Branch Block After Transcatheter Aortic Valve Implantation
16. Impact of Chronic Total Occlusion Revascularization in Patients With Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention
17. Residual platelet reactivity and outcomes with 5 mg prasugrel therapy in elderly patients undergoing percutaneous coronary intervention
18. Comparison of double (360 mg) ticagrelor loading dose with standard (60 mg) prasugrel loading dose in ST-elevation myocardial infarction patients: The Rapid Activity of Platelet Inhibitor Drugs (RAPID) primary PCI 2 study
19. Impact of multivessel disease on infarct size among STEMI patients undergoing primary angioplasty
20. Smoking and infarct size among STEMI patients undergoing primary angioplasty
21. Subacute Stent Thrombosis Related to Kounis Syndrome During Anaphylaxis Induced by Ultrasound Contrast Agent Infusion
22. Percutaneous Coronary Intervention for Multiple Chronic Total Occlusions
23. Comparison of the Degree of Platelet Aggregation Inhibition With Prasugrel Versus Clopidogrel and Clinical Outcomes in Patients With Unprotected Left Main Disease Treated With Everolimus-Eluting Stents
24. Time-to-treatment and infarct size in STEMI patients undergoing primary angioplasty
25. Prognostic Value of Myocardial Injury Following Transcatheter Aortic Valve Implantation
26. Relation of Gender to Infarct Size in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty
27. Preinfarction angina does not affect infarct size in STEMI patients undergoing primary angioplasty
28. Prognostic value of reverse left ventricular remodeling after primary angioplasty for STEMI
29. Residual Platelet Reactivity, Bleedings, and Adherence to Treatment in Patients Having Coronary Stent Implantation Treated With Prasugrel
30. Comparison of Everolimus-Eluting Stent With Paclitaxel-Eluting Stent in Long Chronic Total Occlusions
31. Heart rate as an independent prognostic risk factor in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
32. Evaluation of the influence of age and gender on the relationships between infarct size, infarct severity, and left ventricular ejection fraction in patients successfully treated with primary percutaneous coronary intervention
33. Usefulness of Primary Angioplasty in Nonagenarians With Acute Myocardial Infarction
34. Comparison of Bivalirudin and Unfractionated Heparin Plus Protamine in Patients With Coronary Heart Disease Undergoing Percutaneous Coronary Intervention (from the Antithrombotic Regimens aNd Outcome [ARNO] Trial)
35. Comparison of Effects of Primary Coronary Angioplasty on Left Ventricular Remodeling and Heart Failure in Patients
36. Effectiveness of Primary Percutaneous Coronary Interventions for Stent Thrombosis
37. Clinical Implications of Early Mitral Regurgitation in Patients With Reperfused Acute Myocardial Infarction
38. A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease
39. Significance of Additional ST Segment Elevation in Patients with No Reflow After Angioplasty for Acute Myocardial Infarction
40. Usefulness of 64-Slice Multidetector Computed Tomography for Detecting Drug Eluting In-Stent Restenosis
41. Prevalence, Predictors, Time Course, and Long-Term Clinical Implications of Left Ventricular Functional Recovery After Mechanical Reperfusion for Acute Myocardial Infarction
42. Routine percutaneous coronary intervention in elderly patients with cardiogenic shock complicating acute myocardial infarction
43. ST-Segment Analysis to Predict Infarct Size and Functional Outcome in Acute Myocardial Infarction Treated With Primary Coronary Intervention and Adjunctive Abciximab Therapy
44. Comparison of the usefulness of Doppler-derived deceleration time versus plasma brain natriuretic peptide to predict left ventricular remodeling after mechanical revascularization in patients with ST-elevation acute myocardial infarction and left ventricular systolic dysfunction
45. Abciximab therapy improves 1-month survival rate in unselected patients with acute myocardial infarction undergoing routine infarct artery stent implantation
46. Abciximab therapy improves survival in patients with acute myocardial infarction complicated by early cardiogenic shock undergoing coronary artery stent implantation
47. Relation of time to treatment and mortality in patients with acute myocardial infarction undergoing primary coronary angioplasty
48. Relation between preintervention angiographic evidence of coronary collateral circulation and clinical and angiographic outcomes after primary angioplasty or stenting for acute myocardial infarction
49. Direct infarct artery stenting without predilation and no-reflow in patients with acute myocardial infarction
50. Sex-based differences in clinical and angiographic outcomes after primary angioplasty or stenting for acute myocardial infarction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.